Auriga Maintains a 'Buy' on Nutrisystem (NTRI); Recent Pullback Presents Opportunity
NTRI Hot Sheet
Rating Summary:3 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 18 | New: 27
Auriga maintains a 'Buy' on Nutrisystem (NASDAQ: NTRI) price target of $17.00.
Auriga analyst said, "After rising at the beginning of January likely due to its new promotional campaign, product introductions, and seasonal activity surrounding the commercial weight loss sector, Nutrisystem shares gave back some of its recent gains over the past couple days. The decline coincides with a temporary promotional discount on its Core 4-week offering, which is its shelf stable, ready-to-go meal replacement program. While we acknowledge that last year's aggressive promotions were instigated by lackluster demand, we do not believe this temporary promotion is similar. We consider the drop in Nutrisystem's shares to be excessive considering the limited, short-term nature of this promotion and believe it offers investors an opportunity to once again acquire shares at prices last seen before Christmas. In addition, shares may positively react towards the end of this week as the promotion concludes. We are leaving our estimates unchanged and still recommend investors Buy Nutrisystem shares, which carry a dividend yield of 5.6%, while reiterating our PT."
For an analyst ratings summary and ratings history on Nutrisystem click here. For more ratings news on Nutrisystem click here.
Shares of Nutrisystem closed at $12.56 yesterday, with a 52 week range of $10.46-$22.64.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Auriga analyst said, "After rising at the beginning of January likely due to its new promotional campaign, product introductions, and seasonal activity surrounding the commercial weight loss sector, Nutrisystem shares gave back some of its recent gains over the past couple days. The decline coincides with a temporary promotional discount on its Core 4-week offering, which is its shelf stable, ready-to-go meal replacement program. While we acknowledge that last year's aggressive promotions were instigated by lackluster demand, we do not believe this temporary promotion is similar. We consider the drop in Nutrisystem's shares to be excessive considering the limited, short-term nature of this promotion and believe it offers investors an opportunity to once again acquire shares at prices last seen before Christmas. In addition, shares may positively react towards the end of this week as the promotion concludes. We are leaving our estimates unchanged and still recommend investors Buy Nutrisystem shares, which carry a dividend yield of 5.6%, while reiterating our PT."
For an analyst ratings summary and ratings history on Nutrisystem click here. For more ratings news on Nutrisystem click here.
Shares of Nutrisystem closed at $12.56 yesterday, with a 52 week range of $10.46-$22.64.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UBS Reiterates a 'Buy' on Foot Locker (FL); Raising PT and Estimates on Strong Q1 Results
- Barclays Raises PT and Estimates on Regency Centers (REG); Operations On Track
- Barclays Reiterates an 'Overweight' on DIRECTV (DTV); Three Legs To Stand On
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Dividend, AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
